Onto Another Installment Of The (Alleged) Life Science Fraud Files: Jorge Gomez Is Out As Moderna's CFO, After Three Days... With "Accounting Irregularities" At Sirona.

I've actually talked to this guy a few times, and he seemed very sharp. I guess that might (have been at least part of) the problem (too slick -- by half), and even so, it tells you. . . one never knows.

Certainly, he could be wholly innocent, but this sure doesn't look like that's the case. Seems both companies are now rightly concerned -- as is the SEC's corp. fin., and accounting staff, no doubt.

Here is FiercePharma's excellent reporting, on it all:

. . .Moderna's CFO Jorge Gomez, who only became Moderna's CFO on Monday, is leaving effective immediately, the company said in a Wednesday Securities and Exchange Commission (SEC) filing (PDF). His departure comes after his former employer, Dentsply Sirona, said it couldn't file its first-quarter 2022 financial report because of an internal accounting probe.

Gomez will get a $700,000 salary for his brief stint at Moderna, but he'll lose his signing bonus, relocation reimbursement and any potential equity awards. . . .

[Gomez's former employer, where he was CFO,] Dentsply Sirona -- a manufacturer of dental office supplies -- said it couldn't file its first-quarter 2022 report because its audit and finance committee had started a probe of incentives the company used to sell products to distributors in the second half of 2021. Dentsply Sirona is also investigating whether the company's management directed employees to use the incentives to meet executive compensation targets in 2021. . . .

Two very large, well seasoned public companies; both fleeced -- one, apparently. . . for several years? It seems. . . almost like the bad old '80s are returning. . . in many ways. Yikes.

Out now, smiling into a warm Spring evening -- with a hand-turned ColdStone fresh cherry & vanilla ice cream scoop, on a sugar cone -- yum. . . .

नमस्ते